Sailing through our first TCFD reporting as a NZAMi signatory. This month's insights focuses on Kieger's takeaways on navigating the CDP questionnaire and its relevance to asset managers. While the journey might be challenging, the horizon promises a sustainable, net zero future
What mattered this month in healthcare? The readout of the SELECT study was the single biggest healthcare event of the month. The results may open the door to wide reimbursement for GLP-1 weight-loss drugs. This led to an overreaction with significant price movements amongst many companies as markets just made blanket assumptions of a healthier, thinner world. Find out more in our monthly healthcare newsletter.